News >

Precision Medicine Becomes More Widespread in Breast Cancer

Caroline Seymour
Published: Monday, Jan 27, 2020

Francisco J. Esteva, MD, PhD, director, Breast Medical Oncology Program, and research professor, Department of Pathology, NYU Langone Health Perlmutter Cancer Center

Francisco J. Esteva, MD, PhD

Since the discovery of the estrogen receptor (ER), precision medicine has been an integral component of treatment strategies in breast cancer, said Francisco J. Esteva, MD, PhD, adding that its application is becoming more widespread with the discovery of molecular markers beyond the current disease subtypes.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication